Fenofibrate and blood creatine phosphokinase increased Patient Reports February 11, 2012
Fenofibrate Side Effects Report #5115174-7
Fenofibrate side effect was reported by a Consumer or non-health professional from FRANCE on Jan 20, 2006. Male patient, 57 years of age, was diagnosed with type iib hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: becker's muscular dystrophy, blood creatine phosphokinase increased, mitral valve incompetence, myalgia, myopathy toxic, myositis
. Fenofibrate dosage: unknown. During the same period patient was treated with ATORVASTATIN, INFLUENZA VACCINE, INFLUENZA VACCINE. Patient was hospitalized. Patient recovered.Fenofibrate Side Effects Report #4895812-4
Fenofibrate side effect was reported by a Consumer or non-health professional from FRANCE on Jan 20, 2006. Male patient, 57 years of age, was diagnosed with type iib hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: becker's muscular dystrophy, blood creatine phosphokinase increased, mitral valve incompetence, myalgia, myopathy toxic, myositis
. Fenofibrate dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, INFLUENZA VACCINE, INFLUENZA VACCINE. Patient was hospitalized. Patient recovered.Fenofibrate Side Effects Report #5316749-2
Fenofibrate side effect was reported by a Physician from UNITED STATES on May 01, 2007. Male patient, weighting 224.0 lb, was diagnosed with hypertriglyceridaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, syncope. Fenofibrate dosage: 200 MG DAILY PO. Patient was hospitalized. Patient recovered.
Fenofibrate Side Effects Report #5726847-7
Fenofibrate side effect was reported by a Health Professional from GERMANY on Apr 28, 2008. Male patient, 76 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Fenofibrate dosage: unknown. During the same period patient was treated with NIFEDIPINE, CANDESARTAN CILEXETIL, ATENOLOL, ENALAPRIL MALEATE, DOXAZOSIN MESYLATE. Patient recovered.
Fenofibrate Side Effects Report #5950494-5
Fenofibrate side effect was reported by a Health Professional from GERMANY on Nov 05, 2008. Male patient, 68 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, myoglobin blood increased, pain in extremity. Fenofibrate dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL. Patient recovered.
Fenofibrate Side Effects Report #5953800-0
Fenofibrate side effect was reported by a Health Professional from GERMANY on Nov 05, 2008. Male patient, 68 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, myoglobin blood increased, pain in extremity. Fenofibrate dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL. Patient recovered.
Fenofibrate Side Effects Report #5956908-9
Fenofibrate side effect was reported by a Health Professional from GERMANY on Nov 12, 2008. Male patient, 68 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, myoglobin blood increased, pain in extremity. Fenofibrate dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL. Patient recovered.
Fenofibrate Side Effects Report #5410927-X
Fenofibrate side effect was reported by a Health Professional from GERMANY on Aug 03, 2007. Male patient, 53 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, facial spasm, malaise, musculoskeletal chest pain, musculoskeletal pain, neck pain. Fenofibrate dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, LORATADINE, MECOBALAMIN. Patient recovered.
Fenofibrate Side Effects Report #5505780-X
Fenofibrate side effect was reported by a Health Professional from GERMANY on Oct 26, 2007. Male patient, 53 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, facial spasm, hypothyroidism, malaise, musculoskeletal chest pain, musculoskeletal pain, neck pain. Fenofibrate dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, LORATADINE, MECOBALAMIN. Patient recovered.
Fenofibrate Side Effects Report #5517852-4
Fenofibrate side effect was reported by a Health Professional from GERMANY on Nov 08, 2007. Male patient, 53 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, facial spasm, hypothyroidism, malaise, musculoskeletal chest pain, musculoskeletal pain, neck pain. Fenofibrate dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, LORATADINE, MECOBALAMIN. Patient recovered.
Fenofibrate Side Effects Report #4773353-2
Fenofibrate side effect was reported by a Consumer or non-health professional from FRANCE on Sept 12, 2005. Female patient, 73 years of age, weighting 105.8 lb, was diagnosed with hypercholesterolaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, rotator cuff syndrome, tendonitis. Fenofibrate dosage: unknown. Patient recovered.
Fenofibrate Side Effects Report #4795879-8
Fenofibrate side effect was reported by a Consumer or non-health professional from FRANCE on Sept 12, 2005. Female patient, 73 years of age, weighting 105.8 lb, was diagnosed with hypercholesterolaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle contracture, rotator cuff syndrome, tendonitis. Fenofibrate dosage: unknown. Patient recovered.
Fenofibrate Side Effects Report #4820093-7
Fenofibrate side effect was reported by a Consumer or non-health professional from FRANCE on Sept 12, 2005. Female patient, 73 years of age, weighting 105.8 lb, was diagnosed with hypercholesterolaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle contracture, rotator cuff syndrome, tendonitis. Fenofibrate dosage: unknown. Patient recovered.
Fenofibrate Side Effects Report #5780930-9
Fenofibrate side effect was reported by a Physician from GERMANY on June 12, 2008. Female patient, weighting 127.9 lb, was diagnosed with hypercholesterolaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: abdominal pain
, blood creatine phosphokinase increased, gait disturbance, muscle spasms, muscular weakness, peripheral sensory neuropathy. Fenofibrate dosage: unknown. Patient recovered.Fenofibrate Side Effects Report #5450728-X
Fenofibrate side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2007. Female patient, 67 years of age, was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood pressure abnormal, cardiac aneurysm, cardiac disorder, chest pain
, ejection fraction decreased, musculoskeletal pain, myoglobin urine present, pain in extremity. Fenofibrate dosage: 160 MG QD, PO. During the same period patient was treated with ROSUVASTATIN, HYDROCHLOROTHIAZIDE, OXAPROZIN. Patient was hospitalized. Patient recovered.
Fenofibrate and blood creatine phosphokinase increased 